{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:28:25Z","timestamp":1648744105613},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,2,7]],"date-time":"2015-02-07T00:00:00Z","timestamp":1423267200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Skeletal Radiol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00256-015-2102-z","type":"journal-article","created":{"date-parts":[[2015,2,5]],"date-time":"2015-02-05T21:22:51Z","timestamp":1423171371000},"page":"687-694","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Does the presence of tumor-induced cortical bone destruction at CT have any prognostic value in newly diagnosed diffuse large B-cell lymphoma?"],"prefix":"10.1007","volume":"44","author":[{"given":"Hugo J. A.","family":"Adams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M. H.","family":"de Klerk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Fijnheer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben G. F.","family":"Heggelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan V.","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rutger A. J.","family":"Nievelstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Kwee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,7]]},"reference":[{"issue":"2","key":"2102_CR1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.mayocp.2011.11.007","volume":"87","author":"JO Armitage","year":"2012","unstructured":"Armitage JO. My treatment approach to patients with diffuse large B-cell lymphoma. Mayo Clin Proc. 2012;87(2):161\u201371.","journal-title":"Mayo Clin Proc"},{"key":"2102_CR2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1182\/asheducation-2011.1.498","volume":"2011","author":"JW Friedberg","year":"2011","unstructured":"Friedberg JW. Relapsed\/refractory diffuse large B-cell lymphoma. Hematol Am Soc Hematol Educ Program. 2011;2011:498\u2013505.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"6","key":"2102_CR3","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood-2013-09-524108","volume":"123","author":"Z Zhou","year":"2014","unstructured":"Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A, et al. An enhanced international prognostic index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood. 2014;123(6):837\u201342.","journal-title":"Blood"},{"issue":"Suppl 7","key":"2102_CR4","doi-asserted-by":"crossref","first-page":"vii78","DOI":"10.1093\/annonc\/mds273","volume":"23","author":"H Tilly","year":"2012","unstructured":"Tilly H, Vitolo U, Walewski J, da Silva MG, Shpilberg O, Andre M, et al. Diffuse large B-cell lymphoma (DLBCL): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23 Suppl 7:vii78\u201382.","journal-title":"Ann Oncol"},{"issue":"3","key":"2102_CR5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00259-013-2623-4","volume":"41","author":"HJ Adams","year":"2014","unstructured":"Adams HJ, Kwee TC, de Keizer B, Fijnheer R, de Klerk JM, Nievelstein RA. FDG PET\/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2014;41(3):565\u201374.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"2102_CR6","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00277-011-1353-6","volume":"91","author":"J Hong","year":"2012","unstructured":"Hong J, Lee Y, Park Y, Kim SG, Hwang KH, Park SH, et al. Role of FDG-PET\/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma. Ann Hematol. 2012;91(5):687\u201395.","journal-title":"Ann Hematol"},{"issue":"1","key":"2102_CR7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1182\/blood-2012-12-473389","volume":"122","author":"AB Khan","year":"2013","unstructured":"Khan AB, Barrington SF, Mikhaeel NG, Hunt AA, Cameron L, Morris T, et al. PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement. Blood. 2013;122(1):61\u20137.","journal-title":"Blood"},{"key":"2102_CR8","doi-asserted-by":"crossref","unstructured":"Adams HJ, Kwee TC, Fijnheer R, Dubois SV, Nievelstein RA, de Klerk JM. Bone marrow F-fluoro-2-deoxy-d-glucose positron emission tomography\/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma. Am J Hematol. 2014.","DOI":"10.1002\/ajh.23730"},{"issue":"Suppl 1","key":"2102_CR9","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1007\/s00259-003-1159-4","volume":"30","author":"SJ Vinnicombe","year":"2003","unstructured":"Vinnicombe SJ, Reznek RH. Computerised tomography in the staging of Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma. Eur J Nucl Med Mol Imaging. 2003;30 Suppl 1:S42\u201355.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2102_CR10","volume-title":"Musculoskeletal imaging: a concise multimodality approach","author":"K Bohndorf","year":"2001","unstructured":"Bohndorf K, Imhof H, Pope TL. Musculoskeletal imaging: a concise multimodality approach. New York: Thieme Medical Publishers; 2001."},{"issue":"3","key":"2102_CR11","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1148\/radiol.2373040555","volume":"237","author":"M Tatsumi","year":"2005","unstructured":"Tatsumi M, Cohade C, Nakamoto Y, Fishman EK, Wahl RL. Direct comparison of FDG PET and CT findings in patients with lymphoma: initial experience. Radiology. 2005;237(3):1038\u201345.","journal-title":"Radiology"},{"issue":"3","key":"2102_CR12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2214\/AJR.08.1160","volume":"192","author":"PA Jong de","year":"2009","unstructured":"de Jong PA, van Ufford HM, Baarslag HJ, de Haas MJ, Wittebol SH, Quekel LG, et al. CT and 18\u00a0F-FDG PET for noninvasive detection of splenic involvement in patients with malignant lymphoma. AJR Am J Roentgenol. 2009;192(3):745\u201353.","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"2102_CR13","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3322\/canjclin.55.6.368","volume":"55","author":"JO Armitage","year":"2005","unstructured":"Armitage JO. Staging non-Hodgkin lymphoma. CA Cancer J Clin. 2005;55(6):368\u201376.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"2102_CR14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25(5):579\u201386.","journal-title":"J Clin Oncol"},{"key":"2102_CR15","unstructured":"Privitera GJ. Student study guide with SPSS workbook for statistics for the behavioral sciences: SAGE publications, Inc., 2012."},{"key":"2102_CR16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457\u201381.","journal-title":"J Am Stat Assoc"},{"issue":"6","key":"2102_CR17","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/jmri.24318","volume":"39","author":"HJ Adams","year":"2014","unstructured":"Adams HJ, Kwee TC, Lokhorst HM, Westerweel PE, Fijnheer R, Kersten MJ, et al. Potential prognostic implications of whole-body bone marrow MRI in diffuse large B-cell lymphoma patients with a negative blind bone marrow biopsy. J Magn Reson Imaging. 2014;39(6):1394\u2013400.","journal-title":"J Magn Reson Imaging"},{"issue":"8","key":"2102_CR18","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.2967\/jnumed.112.114710","volume":"54","author":"L Berthet","year":"2013","unstructured":"Berthet L, Cochet A, Kanoun S, Berriolo-Riedinger A, Humbert O, Toubeau M, et al. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18\u00a0F-FDG PET\/CT provides better diagnostic performance and prognostic stratification than does biopsy. J Nucl Med. 2013;54(8):1244\u201350.","journal-title":"J Nucl Med"},{"issue":"1","key":"2102_CR19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/10428194.2011.608452","volume":"53","author":"HY Lee","year":"2012","unstructured":"Lee HY, Kim SJ, Kim K, Ko YH, Kim WS. Bone involvement in patients with stage IV diffuse large B-cell lymphoma: does it have a prognostic value? Leuk Lymphoma. 2012;53(1):173\u20135.","journal-title":"Leuk Lymphoma"},{"key":"2102_CR20","doi-asserted-by":"crossref","unstructured":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma. The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. N Engl J Med. 1993; 329 (14):987\u2013994.","DOI":"10.1056\/NEJM199309303291402"}],"container-title":["Skeletal Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00256-015-2102-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00256-015-2102-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00256-015-2102-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T13:42:06Z","timestamp":1566308526000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00256-015-2102-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,7]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["2102"],"URL":"https:\/\/doi.org\/10.1007\/s00256-015-2102-z","relation":{},"ISSN":["0364-2348","1432-2161"],"issn-type":[{"value":"0364-2348","type":"print"},{"value":"1432-2161","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,7]]}}}